Antibiotic Selection Using Next Generation Sequencing vs Urine Culture
Completed · Not applicable
Conditions studied: Kidney Stone, Renal Stone, Infection, Bacterial
In brief
This is a randomized controlled clinical study evaluating the use of next-generation sequencing (NGS) to improve antibiotic prescribing before ureteroscopy or percutaneous nephrolithotomy.
Key facts
- Study ID
- NCT04404855
- Run by
- The University of Texas Health Science Center at San Antonio
- People needed
- 240
- Starts
- 2019-12-18
- Expected to finish
- 2022-08-31
- Last updated by the study team
- 2024-03-12
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients planning to undergo kidney or bladder stone removal surgery using endoscopy including ureteroscopy and percutaneous nephrolithotomy or any other transurethral procedure
- Age 18 or older
- Able to give informed consent
You may not qualify if…
- Unwilling or unable to provide informed consent
- Age < 18
- Does not meet inclusion criteria
Where it is running
- Audie Murphy VA Hospital — San Antonio, Texas, United States
- The University of Texas Health Science Center at San Antonio, Medical Arts and Research Center — San Antonio, Texas, United States
- University Health System — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.